argenx SE (ARGX)
368.60
-6.40
(-1.71%)
USD |
NASDAQ |
Apr 25, 16:00
368.59
-0.01
(-0.00%)
Pre-Market: 20:00
argenx 1 Year Total Returns (Daily): -5.61% for April 25, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 25, 2024 | -5.61% |
April 24, 2024 | -4.12% |
April 23, 2024 | -3.67% |
April 22, 2024 | -5.30% |
April 19, 2024 | -5.73% |
April 18, 2024 | -4.62% |
April 17, 2024 | -4.62% |
April 16, 2024 | -3.21% |
April 15, 2024 | -1.76% |
April 12, 2024 | -0.44% |
April 11, 2024 | 1.30% |
April 10, 2024 | 1.33% |
April 09, 2024 | -0.83% |
April 08, 2024 | -0.17% |
April 05, 2024 | 3.71% |
April 04, 2024 | 5.28% |
April 03, 2024 | 10.65% |
April 02, 2024 | 6.58% |
April 01, 2024 | 6.64% |
March 28, 2024 | 7.44% |
March 27, 2024 | 10.15% |
March 26, 2024 | 10.28% |
March 25, 2024 | 10.51% |
March 22, 2024 | 12.84% |
March 21, 2024 | 11.01% |
Date | Value |
---|---|
March 20, 2024 | -2.20% |
March 19, 2024 | -0.08% |
March 18, 2024 | 0.52% |
March 15, 2024 | 4.05% |
March 14, 2024 | 5.77% |
March 13, 2024 | 8.26% |
March 12, 2024 | 13.67% |
March 11, 2024 | 12.80% |
March 08, 2024 | 16.03% |
March 07, 2024 | 14.58% |
March 06, 2024 | 14.29% |
March 05, 2024 | 12.01% |
March 04, 2024 | 12.48% |
March 01, 2024 | 6.65% |
February 29, 2024 | 3.82% |
February 28, 2024 | 8.66% |
February 27, 2024 | 11.08% |
February 26, 2024 | 11.96% |
February 23, 2024 | 11.37% |
February 22, 2024 | 10.89% |
February 21, 2024 | 9.19% |
February 20, 2024 | 6.31% |
February 16, 2024 | 6.28% |
February 15, 2024 | 4.70% |
February 14, 2024 | 3.82% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-25.28%
Minimum
Feb 03 2022
192.0%
Maximum
Mar 16 2021
38.62%
Average
30.32%
Median
May 15 2023
1 Year Total Returns (Daily) Benchmarks
TC BioPharm (Holdings) PLC | -94.70% |
Trinity Biotech PLC | -64.81% |
Adaptimmune Therapeutics PLC | -19.70% |
Biodexa Pharmaceuticals Plc | -96.23% |
Merus NV | 122.5% |